These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19917654)

  • 1. IGF1 and its binding proteins 3 and 1 are differentially associated with metabolic syndrome in older men.
    Yeap BB; Chubb SA; Ho KK; Setoh JW; McCaul KA; Norman PE; Jamrozik K; Flicker L
    Eur J Endocrinol; 2010 Feb; 162(2):249-57. PubMed ID: 19917654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of IGF1 and IGFBPs 1 and 3 with all-cause and cardiovascular mortality in older men: the Health In Men Study.
    Yeap BB; Chubb SA; McCaul KA; Ho KK; Hankey GJ; Norman PE; Flicker L
    Eur J Endocrinol; 2011 May; 164(5):715-23. PubMed ID: 21378090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of IGF1 and its binding proteins with abdominal aortic aneurysm and aortic diameter in older men.
    Yeap BB; Chubb SA; McCaul KA; Flicker L; Ho KK; Golledge J; Hankey GJ; Norman PE
    Eur J Endocrinol; 2012 Feb; 166(2):191-7. PubMed ID: 22113073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher IGFBP3 is associated with increased incidence of colorectal cancer in older men independently of IGF1.
    Chan YX; Alfonso H; Paul Chubb SA; Ho KKY; Gerard Fegan P; Hankey GJ; Golledge J; Flicker L; Yeap BB
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):333-340. PubMed ID: 29044573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of plasma IGF1, IGFBP3 and estradiol with leucocyte telomere length, a marker of biological age, in men.
    Yeap BB; Hui J; Knuiman MW; S A Paul C; Ken K Y H; Flicker L; Divitini ML; Arscott GM; Twigg SM; Almeida OP; Hankey GJ; Golledge J; Beilby JP
    Eur J Endocrinol; 2020 Jan; 182(1):23-33. PubMed ID: 31658437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of insulin-like growth factor-I and its binding proteins and testosterone with frailty in older men.
    Yeap BB; Paul Chubb SA; Lopez D; Ho KK; Hankey GJ; Flicker L
    Clin Endocrinol (Oxf); 2013 May; 78(5):752-9. PubMed ID: 23009592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population.
    Cheng I; DeLellis Henderson K; Haiman CA; Kolonel LN; Henderson BE; Freedman ML; Le Marchand L
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3660-6. PubMed ID: 17566087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
    Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS;
    PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of bioactive IGF1 and physiological markers of ageing in healthy adults.
    Vestergaard PF; Hansen M; Frystyk J; Espelund U; Christiansen JS; Jørgensen JO; Fisker S
    Eur J Endocrinol; 2014 Feb; 170(2):229-36. PubMed ID: 24179101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin administration is associated with dose-related changes in IGF bioavailability.
    Narayanan RP; Gittins M; Siddals KW; Oliver RL; Hudson JE; White A; Durrington P; Davies RR; Rutter MK; Gibson JM
    Eur J Endocrinol; 2013 Apr; 168(4):543-8. PubMed ID: 23333902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF1, IGFBP1, and IGFBP3 genes and mammographic density: the Multiethnic Cohort.
    Verheus M; Maskarinec G; Woolcott CG; Haiman CA; Le Marchand L; Henderson BE; Cheng I; Kolonel LN
    Int J Cancer; 2010 Sep; 127(5):1115-23. PubMed ID: 20039319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D supplementation affects the IGF system in men after acute exercise.
    Darr RL; Savage KJ; Baker M; Wilding GE; Raswalsky A; Rideout T; Browne RW; Horvath PJ
    Growth Horm IGF Res; 2016; 30-31():45-51. PubMed ID: 27863277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated free IGF2 levels in localized, early-stage breast cancer in women.
    Espelund U; Cold S; Frystyk J; Ørskov H; Flyvbjerg A
    Eur J Endocrinol; 2008 Nov; 159(5):595-601. PubMed ID: 18719053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IGF1, metabolic syndrome, and incident cardiovascular disease in older people: a population-based study.
    van Bunderen CC; Oosterwerff MM; van Schoor NM; Deeg DJ; Lips P; Drent ML
    Eur J Endocrinol; 2013 Mar; 168(3):393-401. PubMed ID: 23233113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.
    Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE
    Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional and longitudinal relation of IGF1 and IGF-binding protein 3 with lipid metabolism.
    Eggert ML; Wallaschofski H; Grotevendt A; Nauck M; Völzke H; Samietz S; Friedrich N
    Eur J Endocrinol; 2014 Jul; 171(1):9-19. PubMed ID: 24743393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ω-3 fatty acid differentially modulated serum levels of IGF1 and IGFBP3 in men with CVD: a randomized, double-blind placebo-controlled study.
    Gholamhosseini S; Nematipour E; Djazayery A; Javanbakht MH; Koohdani F; Zareei M; Djalali M
    Nutrition; 2015 Mar; 31(3):480-4. PubMed ID: 25701338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families.
    Rosendahl AH; Hietala M; Henningson M; Olsson H; Jernström H
    Breast Cancer Res Treat; 2011 Jun; 127(3):785-94. PubMed ID: 21140206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor 2 (IGF2 ) and IGF-binding protein 1 (IGFBP1) gene variants are associated with overfeeding-induced metabolic changes.
    Ukkola O; Sun G; Bouchard C
    Diabetologia; 2001 Dec; 44(12):2231-6. PubMed ID: 11793026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study.
    Adachi Y; Nojima M; Mori M; Matsunaga Y; Akutsu N; Sasaki S; Endo T; Kurozawa Y; Wakai K; Tamakoshi A;
    Tumour Biol; 2016 Nov; 37(11):15125-15132. PubMed ID: 27662841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.